Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Social Functioning of Kratom(Mitragyna speciosa)Users in Malaysia
Darshan Singh, Christian P. Müller, Balasingam Vicknasingam, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 2, pp. 125-131
Closed Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Following “the Roots” of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries
Eduardo Cinosi, Giovanni Martinotti, Pierluigi Simonato, et al.
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 194
Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam
Brain Research Bulletin (2016) Vol. 126, pp. 41-46
Closed Access | Times Cited: 187
The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse
Andrew C. Kruegel, Oliver Grundmann
Neuropharmacology (2017) Vol. 134, pp. 108-120
Closed Access | Times Cited: 187
An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom use and mental health: A systematic review
Marc T. Swogger, Zach Walsh
Drug and Alcohol Dependence (2017) Vol. 183, pp. 134-140
Closed Access | Times Cited: 133
Experiences of Kratom Users: A Qualitative Analysis
Marc T. Swogger, Elaine Hart, Fire Erowid, et al.
Journal of Psychoactive Drugs (2015) Vol. 47, Iss. 5, pp. 360-367
Closed Access | Times Cited: 130
<p>Current perspectives on the impact of Kratom use</p>
Charles A. Veltri, Oliver Grundmann
Substance Abuse and Rehabilitation (2019) Vol. Volume 10, pp. 23-31
Open Access | Times Cited: 127
Prevalence and motivations for kratom use in a sample of substance users enrolled in a residential treatment program
Kirsten E. Smith, Thomas Lawson
Drug and Alcohol Dependence (2017) Vol. 180, pp. 340-348
Closed Access | Times Cited: 116
Kratom policy: The challenge of balancing therapeutic potential with public safety
Walter C. Prozialeck, Bonnie A. Avery, Edward W. Boyer, et al.
International Journal of Drug Policy (2019) Vol. 70, pp. 70-77
Open Access | Times Cited: 92
Characteristics of deaths associated with kratom use
John Corkery, Peter Streete, Hugh Claridge, et al.
Journal of Psychopharmacology (2019) Vol. 33, Iss. 9, pp. 1102-1123
Open Access | Times Cited: 84
Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users
Darshan Singh, Nelson Jeng‐Yeou Chear, Suresh Narayanan, et al.
Journal of Ethnopharmacology (2019) Vol. 249, pp. 112462-112462
Closed Access | Times Cited: 79
Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Understanding Kratom Use: A Guide for Healthcare Providers
Marc T. Swogger, Kirsten E. Smith, Albert Garcia‐Romeu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Propagative isatin in organic synthesis of spirooxindoles through catalysis
Mohd Asif, Tazeen Azaz, Bhoopendra Tiwari, et al.
Tetrahedron (2023) Vol. 134, pp. 133308-133308
Closed Access | Times Cited: 28
Lewis base-catalyzed synthesis of highly functionalized spirooxindole-pyranopyrazoles and their in vitro anticancer studies
Mohd Asif, Farrukh Aqil, Fatmah Ali Alasmary, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 5, pp. 1001-1015
Closed Access | Times Cited: 23
Ecological Momentary Assessment of Self-Reported Kratom Use, Effects, and Motivations Among US Adults
Kirsten E. Smith, Leigh V. Panlilio, Jeffrey D. Feldman, et al.
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2353401-e2353401
Open Access | Times Cited: 14
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia
Darshan Singh, Suresh Narayanan, Balasingam Vicknasingam, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 3
Open Access | Times Cited: 78
Kratom Withdrawal: A Systematic Review with Case Series
Cornel N. Stanciu, Samantha A. Gnanasegaram, Saeed Ahmed, et al.
Journal of Psychoactive Drugs (2019) Vol. 51, Iss. 1, pp. 12-18
Closed Access | Times Cited: 64
Mitragynine Attenuates Morphine Withdrawal Effects in Rats—A Comparison With Methadone and Buprenorphine
Rahimah Hassan, Pike-See Cheah, Sreenivasan Sasidharan, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 61
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, et al.
Journal of Ethnopharmacology (2017) Vol. 214, pp. 197-206
Closed Access | Times Cited: 59
Pharmacologic and clinical assessment of kratom
C Michael White
American Journal of Health-System Pharmacy (2017) Vol. 75, Iss. 5, pp. 261-267
Closed Access | Times Cited: 57
Page 1 - Next Page

Scroll to top